{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:52:20Z","timestamp":1787237540545,"version":"build-2736575974"},"reference-count":80,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>We evaluated the relevant published studies exploring the association between chemerin concentrations and acute coronary syndromes (ACSs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic search was performed in October 2021 using PubMed, Scopus, Embase, and Cochrane Library. We included full articles and assessed their quality using the Newcastle-Ottawa score.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We found 6 studies in the systematic review and 5 of these were included in our meta-analysis. Mean difference (MD) of 41.69 ng\/mL (95% CI, 10.07\u201373.30), 132.14 ng\/mL (95% CI, \u2212102.12\u2013366.40), and 62.10 ng\/mL (95% CI, 10.31\u2013113.89) in chemerin levels was seen in ACS patients vs control subjects, ACS patients vs stable angina pectoris patients (SAP), and type 2 diabetes mellitus (T2DM) ACS patients vs nondiabetic ACS patients, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Chemerin levels were significantly elevated in patients with ACS compared to controls, as well as in T2DM\u2013ACS patients compared to nondiabetic ACS patients. However, no significant MD in chemerin levels was observed between SAP and ACS patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/labmed\/lmac059","type":"journal-article","created":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T07:14:31Z","timestamp":1651734871000},"page":"552-560","source":"Crossref","is-referenced-by-count":9,"title":["Chemerin Levels in Acute Coronary Syndrome: Systematic Review and Meta-Analysis"],"prefix":"10.1093","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7435-271X","authenticated-orcid":false,"given":"Abdulrahman","family":"Ismaiel","sequence":"first","affiliation":[{"name":"2nd Department of Internal Medicine, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy , Cluj-Napoca , Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Zeeshan","family":"Ashfaq","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy , Cluj-Napoca , Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel-Corneliu","family":"Leucuta","sequence":"additional","affiliation":[{"name":"Department of Medical Informatics and Biostatistics, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy , Cluj-Napoca , Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5840-5137","authenticated-orcid":false,"given":"Mohamed","family":"Ismaiel","sequence":"additional","affiliation":[{"name":"Department of Surgery, St Michael\u2019s Hospital , Dublin , Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilara","family":"Ensar Ismaiel","sequence":"additional","affiliation":[{"name":"Department of Medicine, Tallaght University Hospital , Dublin , Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan-Lucian","family":"Popa","sequence":"additional","affiliation":[{"name":"2nd Department of Internal Medicine, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy , Cluj-Napoca , Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan L","family":"Dumitrascu","sequence":"additional","affiliation":[{"name":"2nd Department of Internal Medicine, \u201cIuliu Hatieganu\u201d University of Medicine and Pharmacy , Cluj-Napoca , Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,6,30]]},"reference":[{"issue":"7","key":"2022110311281282900_CIT0001","first-page":"e9349","article-title":"Global epidemiology of ischemic heart disease: results from the Global Burden of Disease Study","volume":"12","author":"Khan","year":"2020","journal-title":"Cureus."},{"key":"2022110311281282900_CIT0002","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2147\/CLEP.S317787","article-title":"Global burden of ischemic heart disease and attributable risk factors, 1990-2017: a secondary analysis based on the Global Burden of Disease Study 2017","volume":"13","author":"Wang","year":"2021","journal-title":"Clin Epidemiol"},{"issue":"23","key":"2022110311281282900_CIT0003","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239128","article-title":"Extracellular vesicles in diagnosing chronic coronary syndromes the bumpy road to clinical implementation","volume":"21","author":"Dekker","year":"2020","journal-title":"Int J Mol Sci ."},{"key":"2022110311281282900_CIT0004","author":"Kurdi"},{"issue":"2","key":"2022110311281282900_CIT0005","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3122\/jabfm.2015.02.140189","article-title":"Diagnosis and management of acute coronary syndrome: an evidence-based update","volume":"28","author":"Smith","year":"2015","journal-title":"J Am Board Fam Med."},{"issue":"6","key":"2022110311281282900_CIT0006","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.pcad.2016.04.003","article-title":"Coronary atherosclerosis: pathophysiologic basis for diagnosis and management","volume":"58","author":"Boudoulas","year":"2016\/05\/01\/ 2016","journal-title":"Prog Cardiovasc Dis."},{"issue":"2","key":"2022110311281282900_CIT0007","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/CIRCRESAHA.118.313591","article-title":"Immunity and inflammation in atherosclerosis","volume":"124","author":"Wolf","year":"2019","journal-title":"Circ Res."},{"key":"2022110311281282900_CIT0008","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.metabol.2018.10.011","article-title":"Obesity and cardiovascular disease: revisiting an old relationship","volume":"92","author":"Koliaki","year":"2019","journal-title":"Metabolism"},{"key":"2022110311281282900_CIT0009","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2147\/VHRM.S168946","article-title":"Obesity paradox in cardiovascular disease: where do we stand?","volume":"15","author":"Carbone","year":"2019","journal-title":"Vasc Health Risk Manag."},{"key":"2022110311281282900_CIT0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/CMC.S37145","article-title":"Acute coronary syndromes in women: recent treatment trends and outcomes","volume":"10","author":"Graham","year":"2016","journal-title":"Clin Med Insights Cardiol."},{"issue":"2","key":"2022110311281282900_CIT0011","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1152\/physrev.00017.2007","article-title":"Cardiac remodeling in obesity","volume":"88","author":"Abel","year":"2008","journal-title":"Physiol Rev."},{"issue":"9","key":"2022110311281282900_CIT0012","doi-asserted-by":"crossref","first-page":"e12997","DOI":"10.1111\/eci.12997","article-title":"Adipokine dysregulation and adipose tissue inflammation in human obesity","volume":"48","author":"Unamuno","year":"2018","journal-title":"Eur J Clin Invest."},{"key":"2022110311281282900_CIT0013","doi-asserted-by":"crossref","first-page":"602088","DOI":"10.3389\/fcvm.2020.602088","article-title":"Adipose tissue immunomodulation: a novel therapeutic approach in cardiovascular and metabolic diseases","volume":"7","author":"AlZaim","year":"2020","journal-title":"Front Cardiovasc Med."},{"key":"2022110311281282900_CIT0014","doi-asserted-by":"crossref","first-page":"802078","DOI":"10.1155\/2010\/802078","article-title":"The role of adipose tissue and adipokines in obesity-related inflammatory diseases","volume":"2010","author":"Balistreri","year":"2010","journal-title":"Mediators Inflamm."},{"issue":"9","key":"2022110311281282900_CIT0015","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.3390\/ijms20092358","article-title":"Adipose tissue dysfunction as determinant of obesity-associated metabolic complications","volume":"20","author":"Longo","year":"2019","journal-title":"Int J Mol Sci ."},{"key":"2022110311281282900_CIT0016","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3389\/fendo.2020.00354","article-title":"Role of leptin in cardiovascular diseases","volume":"11","author":"Poetsch","year":"2020","journal-title":"Front Endocrinol."},{"issue":"1","key":"2022110311281282900_CIT0017","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cardiores.2006.10.009","article-title":"Adiponectin actions in the cardiovascular system","volume":"74","author":"Hopkins","year":"2007","journal-title":"Cardiovasc Res."},{"issue":"4","key":"2022110311281282900_CIT0018","doi-asserted-by":"crossref","first-page":"897","DOI":"10.5114\/aoms.2016.58664","article-title":"Potential novel biomarkers of cardiovascular dysfunction and disease: cardiotrophin-1, adipokines and galectin-3","volume":"13","author":"Hogas","year":"2017 2017","journal-title":"Arch Med Sci"},{"issue":"15","key":"2022110311281282900_CIT0019","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20153750","article-title":"Chemerin and cancer","volume":"20","author":"Treeck","year":"2019","journal-title":"Int J Mol Sci ."},{"key":"2022110311281282900_CIT0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cca.2021.02.010","article-title":"Chemerin in inflammatory diseases","volume":"517","author":"Su","year":"2021","journal-title":"Clin Chim Acta."},{"key":"2022110311281282900_CIT0021","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.vph.2015.10.007","article-title":"Chemerin in renal dysfunction and cardiovascular disease","volume":"77","author":"Bonomini","year":"2016","journal-title":"Vascul Pharmacol."},{"issue":"2","key":"2022110311281282900_CIT0022","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1530\/JOE-18-0174","article-title":"Chemerin: a multifaceted adipokine involved in metabolic disorders","volume":"238","author":"Helfer","year":"2018","journal-title":"J Endocrinol."},{"issue":"4","key":"2022110311281282900_CIT0023","doi-asserted-by":"crossref","first-page":"6459","DOI":"10.1002\/jcb.27936","article-title":"Chemerin\/ChemR23 axis triggers an inflammatory response in keratinocytes through ROS-sirt1-NF-kappaB signaling","volume":"120","author":"Wang","year":"2019","journal-title":"J Cell Biochem."},{"issue":"25","key":"2022110311281282900_CIT0024","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.2174\/1381612823666170616081256","article-title":"Chemokine like receptor-1 (CMKLR-1) receptor: a potential therapeutic target in management of chemerin induced type 2 diabetes mellitus and cancer","volume":"23","author":"Perumalsamy","year":"2017","journal-title":"Curr Pharm Des."},{"issue":"2","key":"2022110311281282900_CIT0025","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12020-012-9698-8","article-title":"Chemerin: a potential endocrine link between obesity and type 2 diabetes","volume":"42","author":"Roman","year":"2012","journal-title":"Endocrine"},{"issue":"5","key":"2022110311281282900_CIT0026","doi-asserted-by":"crossref","first-page":"R158","DOI":"10.1186\/ar3475","article-title":"Chemerin activates fibroblast-like synoviocytes in patients with rheumatoid arthritis","volume":"13","author":"Kaneko","year":"2011","journal-title":"Arthritis Res Ther."},{"issue":"4","key":"2022110311281282900_CIT0027","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ibd.21091","article-title":"Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn\u2019s disease","volume":"16","author":"Weigert","year":"2010","journal-title":"Inflamm Bowel Dis."},{"key":"2022110311281282900_CIT0028","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12933-014-0145-4","article-title":"Chemerin is a novel biomarker of acute coronary syndrome but not of stable angina pectoris","volume":"13","author":"Ji","year":"2014","journal-title":"Cardiovasc Diabetol."},{"key":"2022110311281282900_CIT0029","article-title":"Abstract P013: association between serum chemerin levels and coronary heart disease: a meta analysis","volume":"133","author":"Pradyumna Agasthi","year":"2018","journal-title":"Circulation."},{"issue":"6","key":"2022110311281282900_CIT0030","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.metabol.2014.02.013","article-title":"Chemerin levels as predictor of acute coronary events: a case-control study nested within the Veterans Affairs Normative Aging Study","volume":"63","author":"Aronis","year":"2014","journal-title":"Metabolism."},{"key":"2022110311281282900_CIT0031","first-page":"169","article-title":"Expression of chemerin correlates with a poor prognosis in female breast cancer patients","volume":"10","author":"El-Sagheer","year":"2018","journal-title":"Breast Cancer (Dove Med Press)."},{"key":"2022110311281282900_CIT0032","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.peptides.2014.08.007","article-title":"Prognostic significance of plasma chemerin levels in patients with gastric cancer","volume":"61","author":"Zhang","year":"2014","journal-title":"Peptides."},{"issue":"11-12","key":"2022110311281282900_CIT0033","first-page":"879","article-title":"Reduced expression of chemerin is associated with a poor prognosis and a lowed infiltration of both dendritic cells and natural killer cells in human hepatocellular carcinoma","volume":"57","author":"Lin","year":"2011","journal-title":"Clin. Lab"},{"issue":"2","key":"2022110311281282900_CIT0034","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s12020-011-9550-6","article-title":"The association of serum chemerin level with risk of coronary artery disease in Chinese adults","volume":"41","author":"Yan","year":"2012","journal-title":"Endocrine."},{"issue":"10","key":"2022110311281282900_CIT0035","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2169\/internalmedicine.50.5025","article-title":"Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with metabolic syndrome","volume":"50","author":"Dong","year":"2011","journal-title":"Intern Med."},{"key":"2022110311281282900_CIT0036","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2022110311281282900_CIT0037","author":"Wells"},{"issue":"5","key":"2022110311281282900_CIT0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v049.i05","article-title":"Closing the gap between methodologists and end-users: R as a computational back-end","volume":"49","author":"Wallace","year":"2012","journal-title":"J Stat Softw."},{"issue":"3","key":"2022110311281282900_CIT0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw."},{"key":"2022110311281282900_CIT0040","article-title":"eds. Cochrane Handbook for Systematic Reviews of Interventions. 2nd ed. Chichester, UK: John Wiley & Sons;","author":"Higgins","year":"2019","journal-title":"Diabetologia."},{"key":"2022110311281282900_CIT0041","first-page":"S501","article-title":"Increased chemerin levels are associated with peripheral arterial occlusive disease and increased urinary albumin excretion rate in type 2 diabetic patients [abstract]","volume":"53","author":"Hoellerl","year":"2010","journal-title":"Diabetologia."},{"issue":"1","key":"2022110311281282900_CIT0042","first-page":"1","article-title":"Lysophospholipids as predictive markers of ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI).","volume":"11","author":"Chorell","year":"2021","journal-title":"Metabolites."},{"issue":"7","key":"2022110311281282900_CIT0043","first-page":"953","article-title":"The elevated levels of plasma chemerin and C-reactive protein in patients with acute coronary syndrome","volume":"31","author":"Aksakal","year":"2015","journal-title":"Cardiol Res Pract."},{"key":"2022110311281282900_CIT0044","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.vph.2015.08.010","article-title":"High plasma chemerin is associated with renal dysfunction and predictive for cardiovascular events\u2014insights from phenotype and genotype characterization","volume":"77","author":"Leiherer","year":"2016","journal-title":"Vascul Pharmacol."},{"key":"2022110311281282900_CIT0045","first-page":"42","article-title":"Plasma chemerin levels are increased in ST elevation myocardial infartion patients with high thrombus burden [abstract]","volume":"18","author":"Ate\u015f","year":"2017","journal-title":"Anatol J Cardiol."},{"key":"2022110311281282900_CIT0046","first-page":"5812704","article-title":"Plasma chemerin levels are increased in ST elevation myocardial infarction patients with high thrombus burden","volume-title":"Cardiol Res Pract.","author":"Ate\u015f","year":"2018"},{"issue":"5","key":"2022110311281282900_CIT0047","first-page":"S74","article-title":"Association of serum chemerin with hs-CRP in patients presenting with acute coronary syndrome with and without diabetes mellitus [abstract]","volume":"62","author":"Kumar","year":"2019","journal-title":"Indian J Pathol Microbiol."},{"issue":"5","key":"2022110311281282900_CIT0048","first-page":"240","article-title":"Comparative effects of atorvastatin 80 mg and rosuvastatin 40 mg on the levels of serum endocan, chemerin, and galectin-3 in patients with acute myocardial infarction","volume":"22","author":"Tun\u00e7ez","year":"2019","journal-title":"Anatol J Cardiol."},{"key":"2022110311281282900_CIT0049","first-page":"52","article-title":"Neutrophil dynamics in acute coronary syndrome [abstract]","volume":"75","author":"Marechal","year":"2020","journal-title":"Acta Clin Belg."},{"issue":"suppl 2","key":"2022110311281282900_CIT0050","first-page":"1263","article-title":"Chemerin in coronary artery disease patients [abstract]","volume":"41","author":"Szpakowicz","year":"2020","journal-title":"Eur Heart J."},{"issue":"1","key":"2022110311281282900_CIT0051","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/JCPC.JCPC_45_20","article-title":"Evaluation of chemerin in acute coronary syndrome and its role in cardiodiabetics","volume":"10","author":"Kumar","year":"2021","journal-title":"J Clin Prevent Cardiol."},{"issue":"6","key":"2022110311281282900_CIT0052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12669\/pjms.36.6.2372","article-title":"Association of serum omentin-1, chemerin, and leptin with acute myocardial infarction and its risk factors","volume":"36","author":"Baig","year":"2020","journal-title":"Pak J Med Sci."},{"issue":"5","key":"2022110311281282900_CIT0053","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2459\/JCM.0000000000000053","article-title":"Serum levels of novel adipokines, omentin-1 and chemerin, in patients with acute myocardial infarction: KOZANI STUDY","volume":"16","author":"Kadoglou","year":"2015","journal-title":"J Cardiovasc Med (Hagerstown)."},{"key":"2022110311281282900_CIT0054","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5812704","article-title":"Plasma chemerin levels are increased in ST elevation myocardial infarction patients with high thrombus burden","author":"Ate\u015f","year":"2018","journal-title":"CardiolRes Pract"},{"issue":"6","key":"2022110311281282900_CIT0055","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.metabol.2014.02.013","article-title":"Chemerin levels as predictor of acute coronary events: a case-control study nested within the Veterans Affairs Normative Aging Study","volume":"63","author":"Aronis","year":"2014","journal-title":"Metab Clin Exp."},{"issue":"13","key":"2022110311281282900_CIT0056","doi-asserted-by":"crossref","first-page":"256","DOI":"10.21037\/atm.2016.06.33","article-title":"Epidemiology of coronary heart disease and acute coronary syndrome","volume":"4","author":"Sanchis-Gomar","year":"2016","journal-title":"Ann Transl Med."},{"issue":"9","key":"2022110311281282900_CIT0057","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics-2020 update: a report from the American Heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation."},{"issue":"2","key":"2022110311281282900_CIT0058","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1185\/030079908X261096","article-title":"One-year costs of ischemic heart disease among patients with acute coronary syndromes: findings from a multi-employer claims database","volume":"24","author":"Menzin","year":"2008","journal-title":"Curr Med Res Opin."},{"issue":"2","key":"2022110311281282900_CIT0059","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/2042018816629894","article-title":"Chemerin as an independent predictor of cardiovascular event risk","volume":"7","author":"Inci","year":"2016","journal-title":"Ther Adv Endocrinol Metab."},{"issue":"9","key":"2022110311281282900_CIT0060","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.3899\/jrheum.140122","article-title":"Circulating concentrations of the novel adipokine chemerin are associated with cardiovascular disease risk in rheumatoid arthritis","volume":"41","author":"Dessein","year":"2014","journal-title":"J Rheumatol."},{"issue":"1","key":"2022110311281282900_CIT0061","doi-asserted-by":"crossref","first-page":"59","DOI":"10.5551\/jat.9647","article-title":"Circulating chemerin level is independently correlated with arterial stiffness","volume":"19","author":"Yoo","year":"2012","journal-title":"J Atheroscler Thromb."},{"issue":"3","key":"2022110311281282900_CIT0062","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2265.2009.03664.x","article-title":"Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes","volume":"72","author":"Weigert","year":"2010","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"2","key":"2022110311281282900_CIT0063","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1530\/EJE-09-0380","article-title":"Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis","volume":"161","author":"Lehrke","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2022110311281282900_CIT0064","doi-asserted-by":"crossref","first-page":"115","DOI":"10.5551\/jat.1735","article-title":"Adipokines in periaortic and epicardial adipose tissue: differential expression and relation to atherosclerosis","volume":"17","author":"Spiroglou","year":"2010","journal-title":"J Atheroscler Thromb."},{"issue":"5","key":"2022110311281282900_CIT0065","doi-asserted-by":"crossref","first-page":"977","DOI":"10.4103\/1319-2442.190867","article-title":"Chemerin: a biomarker for cardiovascular disease in diabetic chronic kidney disease patients","volume":"27","author":"Salama","year":"2016","journal-title":"Saudi J Kidney Dis Transpl."},{"issue":"15","key":"2022110311281282900_CIT0066","doi-asserted-by":"crossref","first-page":"e012091","DOI":"10.1161\/JAHA.119.012091","article-title":"Serum chemerin as a novel prognostic indicator in chronic heart failure","volume":"8","author":"Zhou","year":"2019","journal-title":"J Am Heart Assoc."},{"issue":"1","key":"2022110311281282900_CIT0067","doi-asserted-by":"crossref","first-page":"14171","DOI":"10.1038\/s41598-017-14518-2","article-title":"Association between chemerin, omentin-1 and risk of heart failure in the population-based EPIC-Potsdam study","volume":"7","author":"Menzel","year":"2017","journal-title":"Sci Rep."},{"key":"2022110311281282900_CIT0068","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.12659\/MSM.895866","article-title":"Association of serum chemerin levels with acute ischemic stroke and carotid artery atherosclerosis in a Chinese population","volume":"21","author":"Zhao","year":"2015","journal-title":"Med Sci Monit."},{"key":"2022110311281282900_CIT0069","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cca.2015.05.018","article-title":"Circulating chemerin levels elevated in dilated cardiomyopathy patients with overt heart failure","volume":"448","author":"Zhang","year":"2015","journal-title":"Clin Chim Acta."},{"issue":"6","key":"2022110311281282900_CIT0070","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/MCA.0b013e3283576a60","article-title":"Serum chemerin levels are associated with the presence and extent of coronary artery disease","volume":"23","author":"Xiaotao","year":"2012","journal-title":"Coron Artery Dis."},{"issue":"3","key":"2022110311281282900_CIT0071","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4093\/dmj.2011.35.3.248","article-title":"Relationship between chemerin levels and cardiometabolic parameters and degree of coronary stenosis in Korean patients with coronary artery disease","volume":"35","author":"Hah","year":"2011","journal-title":"Diabetes Metab J."},{"issue":"1","key":"2022110311281282900_CIT0072","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1139\/cjpp-2017-0272","article-title":"Serum levels of chemerin, apelin, vaspin, and omentin-1 in obese type 2 diabetic Egyptian patients with coronary artery stenosis","volume":"96","author":"Motawi","year":"2018","journal-title":"Can J Physiol Pharmacol."},{"issue":"5-6","key":"2022110311281282900_CIT0073","first-page":"539","article-title":"Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with type 2 diabetes","volume":"58","author":"Lin","year":"2012","journal-title":"Clin Lab."},{"issue":"12","key":"2022110311281282900_CIT0074","first-page":"5461","article-title":"Association of serum chemerin levels with the severity of coronary artery disease in patients with metabolic syndrome","volume":"7","author":"Aksan","year":"2014","journal-title":"Int J Clin Exp Med."},{"issue":"8","key":"2022110311281282900_CIT0075","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3390\/biom11081149","article-title":"Serum chemerin concentration is associated with proinflammatory status in chronic coronary syndrome","volume":"11","author":"Szpakowicz","year":"2021","journal-title":"Biomolecules."},{"key":"2022110311281282900_CIT0076","doi-asserted-by":"crossref","first-page":"8693516","DOI":"10.1155\/2019\/8693516","article-title":"Increased circulating chemerin in relation to chronic microvascular complications in patients with type 2 diabetes","volume":"2019","author":"Gu","year":"2019","journal-title":"Int J Endocrinol."},{"issue":"5","key":"2022110311281282900_CIT0077","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.metabol.2011.10.008","article-title":"Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity","volume":"61","author":"Chakaroun","year":"2012","journal-title":"Metabolism."},{"issue":"1","key":"2022110311281282900_CIT0078","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1038\/s41598-018-21387-w","article-title":"Red blood cells are dynamic reservoirs of cytokines","volume":"8","author":"Karsten","year":"2018","journal-title":"Sci Rep."},{"issue":"6","key":"2022110311281282900_CIT0079","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10059-012-0012-7","article-title":"Differential patterns of serum concentration and adipose tissue expression of chemerin in obesity: adipose depot specificity and gender dimorphism","volume":"33","author":"Alfadda","year":"2012","journal-title":"Mol Cells."},{"issue":"6","key":"2022110311281282900_CIT0080","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1210\/en.2009-0794","article-title":"Serum chemerin levels vary with time of day and are modified by obesity and tumor necrosis factor-\u03b1","volume":"151","author":"Parlee","year":"2010","journal-title":"Endocrinology."}],"container-title":["Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/labmed\/article-pdf\/53\/6\/552\/46777024\/lmac059.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/labmed\/article-pdf\/53\/6\/552\/46777024\/lmac059.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T07:41:25Z","timestamp":1667461285000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/labmed\/article\/53\/6\/552\/6622005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,30]]},"references-count":80,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6,30]]},"published-print":{"date-parts":[[2022,11,3]]}},"URL":"https:\/\/doi.org\/10.1093\/labmed\/lmac059","relation":{},"ISSN":["0007-5027","1943-7730"],"issn-type":[{"value":"0007-5027","type":"print"},{"value":"1943-7730","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,11,1]]},"published":{"date-parts":[[2022,6,30]]}}}